Taylor S, Demeyin (Nuabor) W, Muls A, Ferguson C, Farnell DJ, Cohen D, Andreyev J, Green J, Smith L, Ahmedzai S, Pickett S, Nelson A, Staffurth J. Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project. BMJ Open. 2016 Oct 3;6(10):e011773. doi: 10.1136/bmjopen-2016-011773
Gramling R, Eaton CB, Rothman KJ, Cabral H, Silliman RA, Lash TL. Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women. Epidemiology. 2009 Sep 1;20(5):752-6.
Sorensen HT, Pedersen L, Norgaard M, Rothman KJ, Lash TL. No excess risk of breast cancer in mothers of boys with hypospadias. Epidemiology. 2006 Nov 30;17(6):706-7.
Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A. Analgesic drug use and risk of ovarian cancer. Epidemiology. 2006 Jan 1;17(1):104-7.
Rothman KJ, Chou CK, Morgan R, Balzano Q, Guy AW, Funch DP, PrestonMartin S, Mandel J, Steffens R, Carlo G. Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology. 1996 May 7;7(3):291-8.
Johannes CB, Kaufman DW, Rosenberg L, Palmer JR, Stolley PD, Lewis, Jr JL, Zauber AG. Side of origin of epithelial ovarian cancer. BMJ Open. 1992 Jan 4;304(6818):27-8.